Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRELISA: Premedication for Less Invasive Surfactant Administration
NCT05065424Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Apr 2022
- Primary completion
- Mar 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fentanyl, atropine in respiratory distress syndrome (RDS), sponsored by UT Southwestern Medical Center. Started Apr 2022; status: completed.
02
Drugs
fentanylatropine
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on NCT05065424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05065424.